210 related articles for article (PubMed ID: 9621276)
1. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease.
Ramasubbu K; Gretz N; Bachmann S
J Am Soc Nephrol; 1998 Jun; 9(6):937-45. PubMed ID: 9621276
[TBL] [Abstract][Full Text] [Related]
2. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
Pey R; Bach J; Schieren G; Gretz N; Hafner M
In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity of cyst epithelium in human renal cystic diseases.
Nadasdy T; Laszik Z; Lajoie G; Blick KE; Wheeler DE; Silva FG
J Am Soc Nephrol; 1995 Jan; 5(7):1462-8. PubMed ID: 7703384
[TBL] [Abstract][Full Text] [Related]
4. Polycystic kidney disease in Han:SPRD Cy rats is associated with elevated expression and mislocalization of SamCystin.
Nagao S; Morita M; Kugita M; Yoshihara D; Yamaguchi T; Kurahashi H; Calvet JP; Wallace DP
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1078-86. PubMed ID: 20719982
[TBL] [Abstract][Full Text] [Related]
5. Renal endothelin system in polycystic kidney disease.
Hocher B; Zart R; Schwarz A; Vogt V; Braun C; Thöne-Reineke C; Braun N; Neumayer HH; Koppenhagen K; Bauer C; Rohmeiss P
J Am Soc Nephrol; 1998 Jul; 9(7):1169-77. PubMed ID: 9644626
[TBL] [Abstract][Full Text] [Related]
6. ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease.
Hocher B; Kalk P; Slowinski T; Godes M; Mach A; Herzfeld S; Wiesner D; Arck PC; Neumayer HH; Nafz B
J Am Soc Nephrol; 2003 Feb; 14(2):367-76. PubMed ID: 12538737
[TBL] [Abstract][Full Text] [Related]
7. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
[TBL] [Abstract][Full Text] [Related]
8. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
[TBL] [Abstract][Full Text] [Related]
9. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of type II sodium/phosphate cotransporter in polycystic kidney disease.
Vogel M; Kränzlin B; Biber J; Murer H; Gretz N; Bachmann S
J Am Soc Nephrol; 2000 Oct; 11(10):1926-1932. PubMed ID: 11004225
[TBL] [Abstract][Full Text] [Related]
11. Kidney Injury Molecule-1 Is Specifically Expressed in Cystically-Transformed Proximal Tubules of the PKD/Mhm (cy/+) Rat Model of Polycystic Kidney Disease.
Gauer S; Urbschat A; Gretz N; Hoffmann SC; Kränzlin B; Geiger H; Obermüller N
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231899
[TBL] [Abstract][Full Text] [Related]
12. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
[TBL] [Abstract][Full Text] [Related]
13. Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease.
Wahl PR; Le Hir M; Vogetseder A; Arcaro A; Starke A; Waeckerle-Men Y; Serra AL; Wuthrich RP
Nephrology (Carlton); 2007 Aug; 12(4):357-63. PubMed ID: 17635750
[TBL] [Abstract][Full Text] [Related]
14. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
Cowley BD; Ricardo SD; Nagao S; Diamond JR
Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease.
Schäfer K; Gretz N; Bader M; Oberbäumer I; Eckardt KU; Kriz W; Bachmann S
Kidney Int; 1994 Jul; 46(1):134-52. PubMed ID: 7933831
[TBL] [Abstract][Full Text] [Related]
16. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.
Xu T; Wang NS; Fu LL; Ye CY; Yu SQ; Mei CL
Mol Biol Rep; 2012 Jul; 39(7):7743-53. PubMed ID: 22415852
[TBL] [Abstract][Full Text] [Related]
18. Renal remodelling in dietary protein modified rat polycystic kidney disease.
Bankovic-Calic N; Eddy A; Sareen S; Ogborn MR
Pediatr Nephrol; 1999 Sep; 13(7):567-70. PubMed ID: 10460502
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.
Berthier CC; Wahl PR; Le Hir M; Marti HP; Wagner U; Rehrauer H; Wüthrich RP; Serra AL
Nephrol Dial Transplant; 2008 Mar; 23(3):880-9. PubMed ID: 18042615
[TBL] [Abstract][Full Text] [Related]
20. Alterations of cathepsins B, H and L in proximal tubules from polycystic kidneys of the Han:SPRD rat.
Schaefer L; Han X; Gretz N; Schaefer RM
Kidney Int; 1996 Aug; 50(2):424-31. PubMed ID: 8840269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
